Status:
COMPLETED
Modulating Pain Using Transcranial Alternating Stimulation (tACS) in Healthy Human Subjects
Lead Sponsor:
Technical University of Munich
Collaborating Sponsors:
German Research Foundation
Conditions:
Experimental Pain in Healthy Human Subjects
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Pain is a highly complex and subjective phenomenon which results from the dynamic integration of sensory and contextual (i.e. cognitive, emotional, and motivational) processes. Recent evidence suggest...
Eligibility Criteria
Inclusion
- aged 18-65 years
- Right-handedness
- Written informed consent
Exclusion
- Pregnancy
- Neurological or psychiatric diseases (e.g. epilepsy, stroke, depression, anxiety disorders)
- Severe general illnesses (e.g. tumors, diabetes)
- Skin diseases (e.g. dermatitis, psoriasis or eczema)
- Current or recurrent pain
- Regular intake of medication
- Surgical procedures involving the head or spinal cord
- Head trauma followed by impairment of consciousness
- Past fainting spells or syncopes
- Metal (except titanium) or electronic implants
- Side-effects following previous electrical or magnetic stimulation
- Side-effects following previous thermal stimulation
Key Trial Info
Start Date :
April 15 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 23 2019
Estimated Enrollment :
39 Patients enrolled
Trial Details
Trial ID
NCT03805854
Start Date
April 15 2019
End Date
October 23 2019
Last Update
June 4 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Neurology, Klinikum rechts der Isar, Technische Universität München
Munich, Bavaria, Germany, 81675